Madrigal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. 

CEO
William J. Sibold
CEOWilliam J. Sibold
Employees
528
Employees528
Headquarters
West Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded
2000
Founded2000
Employees
528
Employees528

MDGL Key Statistics

Market cap
11.27B
Market cap11.27B
Price-Earnings ratio
-38.17
Price-Earnings ratio-38.17
Dividend yield
Dividend yield
Average volume
280.49K
Average volume280.49K
High today
$506.40
High today$506.40
Low today
$492.30
Low today$492.30
Open price
$504.36
Open price$504.36
Volume
180.91K
Volume180.91K
52 Week high
$615.00
52 Week high$615.00
52 Week low
$265.00
52 Week low$265.00

Stock Snapshot

The current Madrigal Pharmaceuticals(MDGL) stock price is $496.10, with a market capitalization of 11.27B. The stock trades at a price-to-earnings (P/E) ratio of -38.17.

During the trading session on 2026-01-28, Madrigal Pharmaceuticals(MDGL) shares reached a daily high of $506.40 and a low of $492.30. At a current price of $496.10, the stock is +0.8% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 180.91K, compared to an average daily volume of 280.49K.

The stock's 52-week range extends from a low of $265.00 to a high of $615.00.

The stock's 52-week range extends from a low of $265.00 to a high of $615.00.

MDGL News

TipRanks 2d
Top Madrigal Pharma Insiders Quietly Cash Out in a Wave of Share Sales

New insider activity at Madrigal Pharmaceuticals ( (MDGL) ) has taken place on January 26, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and...

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
11.1%
Sell
5.6%

People also own

Based on the portfolios of people who own MDGL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.